For researchers new to peptide science, our peptide reconstitution guide provides step-by-step instructions for preparing research-grade compounds correctly
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
What are the storage and handling recommendations
2011 DOI: 10.1152/japplphysiol.00945.2010 PMID: 21030672 Read on PubMed Neural Regeneration Research Pentadecapeptide BPC 157 and the central nervous system Vukojevic J, Milavi M, Perovi D, et al
Enhancement products sold online may contain much more or much less of the advertised ingredient than the label claims
